DS
BCDA icon

DRW Securities’s BioCardia BCDA Stock Holding History

DRW Securities’s Portfolio BCDA Stock Details BCDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-57,607
Closed -$72K – 1298
2025
Q4 		$72K Buy
+57,607
New +$78.3K ﹤0.01% 1094

Other funds holding BCDA

CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
PP
Pingora Partners Wilson, Wyoming $169M AUM 56.08% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

DRW Securities's BCDA Position: Q1 2026 in Review

DRW Securities sold out of BioCardia (BCDA) in Q1 2026, closing a stake of 57,607 shares — an estimated $72K sold.

DRW Securities first reported a position in BCDA in Q4 2025 and held it in 1 quarter. The position peaked at $72K in Q4 2025. 18 funds tracked by Wall St. Rank hold BCDA as of Q1 2026.

  • DRW Securities reported no remaining BioCardia position as of Q1 2026 after selling out during the quarter.
  • DRW Securities sold 57,607 BioCardia shares in Q1 2026, an estimated $72K.
  • DRW Securities first reported a position in BioCardia in Q4 2025 and held it in 1 quarter.
  • DRW Securities's BioCardia position peaked at $72K in Q4 2025.
  • 18 funds tracked by Wall St. Rank held BioCardia as of Q1 2026.

Based on DRW Securities's 13F filing for Q1 2026, filed 13 May 2026.